<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30278541</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>10</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1536-5964</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>97</Volume>                    <Issue>39</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Medicine</Title>                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>            </Journal>            <ArticleTitle>Repeated resection-associated breast angiosarcoma: A case report.</ArticleTitle>            <Pagination>                <MedlinePgn>e12513</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000012513</ELocationID>            <Abstract>                <AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">As a very rare vascular tumor, breast angiosarcoma (AS) can be divided into primary and second breast AS. However, the latter is slightly more commonly detected in clinical practice. Radiation post mastectomy is the common cause for the secondary breast AS, and although there are other reasons, it is still quite rare. In the present study, we reported a rare case of breast AS and summarized the relevant literatures so that to conduce to diagnose AS.</AbstractText>                <AbstractText Label="PATIENT CONCERNS" NlmCategory="UNASSIGNED">A 50-year-old female with a history of right breast neoplasm was treated with repeat lumpectomy for 4 times during 8 years.</AbstractText>                <AbstractText Label="DIAGNOSES" NlmCategory="UNASSIGNED">Mammogram and ultrasound examination demonstrated a possible malignancy (BIRADS-4B and BI-RADS-4C, respectively). Immunohistochemically positive for endothelial markers CD31, CD34, ERG, and FVIII-R-Ag.</AbstractText>                <AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">The patient underwent a right mastectomy with sentinel lymph node biopsy by our multidisciplinary team and no other therapy was given postsurgery.</AbstractText>                <AbstractText Label="OUTCOMES" NlmCategory="RESULTS">The patient had no recurrence after 3 months.</AbstractText>                <AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">Based on our findings, we concluded that repeated resection might be a risk factor for the breast AS, especially for a gradual pathological evolution from benign to malignant. This case showed a very rare cause for angiomatosis of breast, and the patient had a successful outcome after a simple mastectomy.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Tang</LastName>                    <ForeName>Tiantian</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, P. R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Haiping</ForeName>                    <Initials>H</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D002363">Case Reports</PublicationType>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Medicine (Baltimore)</MedlineTA>            <NlmUniqueID>2985248R</NlmUniqueID>            <ISSNLinking>0025-7974</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C072312">ERG protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000071230">Transcriptional Regulator ERG</NameOfSubstance>            </Chemical>        </ChemicalList>        <SupplMeshList>            <SupplMeshName Type="Disease" UI="C536368">Angiosarcoma of the breast</SupplMeshName>        </SupplMeshList>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2007 Jul 1;110(1):173-8</RefSource>                <PMID Version="1">17541936</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2007 Mar;242(3):725-34</RefSource>                <PMID Version="1">17325063</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Surg Case Rep. 2016;20S:12-5</RefSource>                <PMID Version="1">26867719</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Clin Oncol. 2009 Dec;32(6):582-6</RefSource>                <PMID Version="1">19581792</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2017 Dec;116(8):1056-1061</RefSource>                <PMID Version="1">29205355</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2005 Mar-Apr;11(2):115-23</RefSource>                <PMID Version="1">15730457</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 Apr;132(3):1081-8</RefSource>                <PMID Version="1">22207278</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 1997 Aug;31(2):189-95</RefSource>                <PMID Version="1">9279573</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiother Oncol. 2007 Dec;85(3):355-61</RefSource>                <PMID Version="1">18023492</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2018 Jul;24(4):487-492</RefSource>                <PMID Version="1">29476585</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2010 Aug;122(3):883-7</RefSource>                <PMID Version="1">20087653</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2018 Jan;24(1):91-93</RefSource>                <PMID Version="1">28597488</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2006 Jul-Aug;12(4):371-4</RefSource>                <PMID Version="1">16848851</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Dis. 2018;37(3):133-138</RefSource>                <PMID Version="1">29286911</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Clin Oncol. 2007 Dec;30(6):570-3</RefSource>                <PMID Version="1">18091049</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2011 Feb;135(2):268-72</RefSource>                <PMID Version="1">21284449</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001940" MajorTopicYN="Y">Breast</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006394" MajorTopicYN="Y">Hemangiosarcoma</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015412" MajorTopicYN="N">Mastectomy, Segmental</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009364" MajorTopicYN="Y">Neoplasm Recurrence, Local</DescriptorName>                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000071230" MajorTopicYN="N">Transcriptional Regulator ERG</DescriptorName>                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30278541</ArticleId>            <ArticleId IdType="doi">10.1097/MD.0000000000012513</ArticleId>            <ArticleId IdType="pii">00005792-201809280-00063</ArticleId>            <ArticleId IdType="pmc">PMC6181542</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>